You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › March › 17
Lilly
4 months ago
"On balance, we do not like the risk/reward balance in Lilly shares," the analysts wrote.
Eli Lilly catches a downgrade as HSBC warns of an overhyped obesity drug market ○
HSBC signals a potential cooling period for the red-hot obesity drug trade.
page 1 of 1